Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Showing 15 posts of 2295 posts found.

FlyPharma Europe, Vienna: the early bird deal for FlyPharma Vienna closes on 24 May

May 9, 2023 Business Services, Conferences Conference, flypharma

Act now! The early bird deal for FlyPharma Vienna closes on 24 May. Contact Angela Heath, conference director, email angela@samedanltd.com for …
News
Press release

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa

April 27, 2023 Business Services CHMP, Cosentyx, Dermatology, Novartis

Basel, April 26, 2023 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …
News
Press release

Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology

April 26, 2023 Business Services

Boston, Massachusetts, April 26, 2023 – Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, …
News
Press release

Epsilogen announces significant expansion of management team with three new senior hires

April 26, 2023 Business Services

London, 26 April 2023 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to …
News
Press release

Real-world data analysis shows significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr® app in UK users with type 2 diabetes

April 26, 2023 Business Services

Burgess Hill, 26 April 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that real world data shows a …
News
Press release

MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases

April 25, 2023 Business Services

London, United Kingdom, April 25, 2023 — MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a multi-target …
News
Press release

PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

April 25, 2023 Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …
News
Press release

Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

April 25, 2023 Business Services

London, UK: Commercial trials for psychedelics-assisted medical treatments will now have access to state-of-the-art brain scanning technology thanks to a …
News
Press release

Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference

April 25, 2023 Business Services

Cambridge, UK, April 25, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to …
News
Press release

National Institute for Health and Care Excellence recommends Darzalex® (daratumumab) with bortezomib and dexamethasone for routine use on the NHS as treatment for multiple myeloma

April 24, 2023 Business Services

High Wycombe, 24 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to announce that the …
News
Press release

Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer

April 24, 2023 Business Services

Cambridge, UK, 24th April 2023: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, …
News
Press release

Incyte Announces European Commission Approval of Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents

April 24, 2023 Business Services

WILMINGTON, Del. – April 20, 2023 – Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has granted a marketing …
News
Press release

Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

April 24, 2023 Business Services

BEERSE, Belgium, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission …
News
Press release

NICE gives green light to ibrutinib plus venetoclax as first-line treatment option for chronic lymphocytic leukaemia

April 24, 2023 Business Services

High Wycombe, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson is pleased to announce that the …
News
Press release

Breye Therapeutics Strengthens Management Team and Board

April 20, 2023 Business Services

Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal …
News
Press release
News alerts and subscriptions

Latest content

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

June 9, 2023

Astellas Pharma and BMT CTN announce phase 3 data for gilteritinib

June 9, 2023

Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

June 8, 2023

Inventiva and Echosens collaborate to bring awareness to NASH and encourage screening for at-risk patients

June 8, 2023

Inizio launches strategic engagement offering to transform customer experiences

June 7, 2023